Pharmacology and Toxicology
Showing page 7 of 22 pages of list content
-
Modeling osteoporosis to design and optimize pharmacologic therapies comprising multiple drug types
This article's authors -
A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis and Obesity
This article's authors -
Targeting Neutrophils Extracellular Traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
This article's authors -
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
This article's authors -
Robust and durable prophylactic protection conferred by RNA interference in preclinical models of SARS-CoV-2
This article's authors -
Differential Activity of Repurposed Drugs as Receptor Binding Domain Antagonists for Omicron and Native Strains of SarsCov2
This article's authors -
Lack of antiviral activity of probenecid in Vero E6 cells and Syrian golden hamsters: a need for better understanding of inter-lab differences in preclinical assays
This article's authors -
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs
This article's authors -
Common coupling map advances GPCR-G protein selectivity
This article's authors -
In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals
This article's authors